Article info

Original research
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

Authors

  1. Correspondence to Niels Halama; niels.halama{at}nct-heidelberg.de
View Full Text

Citation

Suarez-Carmona M, Williams A, Schreiber J, et al
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

Publication history

  • Accepted September 7, 2021
  • First published October 4, 2021.
Online issue publication 
October 04, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.